These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29622507)

  • 21. Mortality prognosis of NGAL, NTproBNP, hsTnT, and GRACE score in patients with acute coronary syndrome.
    Viet Tran A; To Tran N; Duy Nguyen K; Thi Nguyen D; Hoang Ngo T
    Int J Cardiol Heart Vasc; 2024 Feb; 50():101338. PubMed ID: 38419605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease.
    Sivalingam Z; Erik Magnusson N; Grove EL; Hvas AM; Dalby Kristensen S; Bøjet Larsen S
    Scand J Clin Lab Invest; 2018 Oct; 78(6):470-476. PubMed ID: 30261750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial measurements of neutrophil gelatinase-associated lipocalin: prognostic value in patients with ST-segment elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Lim YM; Moon JY; Min D; Kim SH; Yang WI; Kim WJ; Sung JH; Kim IJ; Lim SW; Cha DH
    Coron Artery Dis; 2017 Dec; 28(8):690-696. PubMed ID: 28737526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
    Mjelva ØR; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen DW
    Eur J Prev Cardiol; 2016 Jul; 23(11):1130-40. PubMed ID: 26635361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Neutrophil Gelatinase-Associated Lipocalin for the Assessment of Structural versus Functional Renal Damage among ST-Segment Elevation Myocardial Infarction Patients.
    Rozenfeld KL; Zahler D; Shtark M; Goldiner I; Keren G; Banai S; Shacham Y
    Blood Purif; 2020; 49(5):560-566. PubMed ID: 32074603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease.
    Sahinarslan A; Kocaman SA; Bas D; Akyel A; Ercin U; Zengin O; Timurkaynak T
    Coron Artery Dis; 2011 Aug; 22(5):333-8. PubMed ID: 21558855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.
    Nymo SH; Ueland T; Askevold ET; Flo TH; Kjekshus J; Hulthe J; Wikstrand J; McMurray J; Van Veldhuisen DJ; Gullestad L; Aukrust P; Yndestad A
    J Intern Med; 2012 May; 271(5):436-43. PubMed ID: 22211640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
    Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
    Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of plasma neutrophil gelatinase-associated lipocalin in patients with heart failure.
    Villacorta H; Santos RA; Marroig MA; Pereira GP; Xavier AR; Kanaan S
    Rev Port Cardiol; 2015; 34(7-8):473-8. PubMed ID: 26162288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with ST-Elevation Myocardial Infarction and Its Association with Acute Kidney Injury and Mortality.
    Højagergaard MA; Beske RP; Hassager C; Holmvang L; Jensen LO; Shacham Y; Meyer MAS; Moeller JE; Helgestad OKL; Mark PD; Møgelvang R; Frydland M
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil Gelatinase-Associated Lipocalin for the Assessment of Reversible versus Persistent Renal Tubular Damage in ST-Segment Myocardial Infarction Patients.
    Banai A; Rozenfeld KL; Loewenstein I; Zahler D; Shtark M; Goldiner I; Banai S; Shacham Y
    Blood Purif; 2021; 50(6):925-930. PubMed ID: 33756457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study.
    Kunutsor SK; Flores-Guerrero JL; Kieneker LM; Nilsen T; Hidden C; Sundrehagen E; Seidu S; Dullaart RPF; Bakker SJL
    Clin Chim Acta; 2018 Nov; 486():66-75. PubMed ID: 30036522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
    He PC; Duan CY; Liu YH; Wei XB; Lin SG
    BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [NGAL as a marker for some extrarenal complications in acute coronary syndrome].
    Shalenkova MA; Mikhailova ZD; Klimkin PF
    Kardiologiia; 2018 SMar; (S3):19-26. PubMed ID: 29782286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study.
    George M; Shanmugam E; Srivatsan V; Vasanth K; Ramraj B; Rajaram M; Jena A; Sridhar A; Chaudhury M; Kaliappan I
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):275-84. PubMed ID: 25814534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of plasma galectin-3 levels in acute coronary syndrome.
    Obeid S; Yousif N; Davies A; Loretz R; Saleh L; Niederseer D; Noor HA; Amin H; Mach F; Gencer B; Räber L; Windecker S; Templin C; Nanchen D; Rodondi N; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2020 Dec; 9(8):869-878. PubMed ID: 33300826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.